Ian F. Smith

2018

In 2018, Ian F. Smith earned a total compensation of $4.6M as Former EVP & Chief Operating and Interim Chief Financial Officer at Vertex Pharmaceuticals, a 22% decrease compared to previous year.

Compensation breakdown

Option Awards$1,136,785
Salary$850,000
Stock Awards$2,625,244
Other$14,105
Total$4,626,134

Smith received $2.6M in stock awards, accounting for 57% of the total pay in 2018.

Smith also received $1.1M in option awards, $850K in salary and $14.1K in other compensation.

Rankings

In 2018, Ian F. Smith's compensation ranked 2,245th out of 14,244 executives tracked by ExecPay. In other words, Smith earned more than 84.2% of executives.

ClassificationRankingPercentile
All
2,245
out of 14,244
84th
Division
Manufacturing
819
out of 5,758
86th
Major group
Chemicals And Allied Products
272
out of 2,119
87th
Industry group
Drugs
220
out of 1,808
88th
Industry
Pharmaceutical Preparations
171
out of 1,382
88th

Pay ratio

Ian F. Smith's Pay$4,626,134
Median Employee's Pay$232,178
Pay Ratio

20

to 1

In 2018, the annual total compensation of Ian F. Smith was $4,626,134.

The annual total compensation of the median employee at Vertex Pharmaceuticals was $232,178.

The ratio of Ian F. Smith's pay to the pay of median employee was therefore 20 to one.

Source: SEC filing on April 26, 2019.

Smith's colleagues

We found six more compensation records of executives who worked with Ian F. Smith at Vertex Pharmaceuticals in 2018.

2018

Jeffrey Leiden

Vertex Pharmaceuticals

Chief Executive Officer

2018

Jeffrey Chodakewitz

Vertex Pharmaceuticals

Chief Medical Officer

2018

Amit Sachdev

Vertex Pharmaceuticals

EVP & Chief Regulatory Officer

2018

Michael Parini

Vertex Pharmaceuticals

EVP & Chief Legal and Administrative Officer

2018

Stuart Arbuckle

Vertex Pharmaceuticals

EVP & Chief Commercial Officer

2018

Thomas Graney

Vertex Pharmaceuticals

Chief Financial Officer

News

You may also like